The potentiation of sinus arrhythmia by vasoactive intestinal polypeptide (VIP) in the anaesthetized dog

Neuropeptides

Volumn 35, Issue 5-6, 2001, Pages 238-243

  Markos, F ^a   Snow, H M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ATENOLOL; LIDOCAINE; NORADRENALIN; VASOACTIVE INTESTINAL POLYPEPTIDE; ADRENERGIC RECEPTOR STIMULATING AGENT; PEPTIDE FRAGMENT;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CHRONOTROPISM; CONTROLLED STUDY; DOG; HEART RATE VARIABILITY; NONHUMAN; PRIORITY JOURNAL; SINUS ARRHYTHMIA; SYMPATHETIC NERVE; ADRENERGIC NERVE; ANIMAL; DRUG EFFECT; ELECTROSTIMULATION; HEART; HEART RATE; METABOLISM; PHYSIOLOGY;

CANIS FAMILIARIS;

ADRENERGIC FIBERS; ANIMALS; ARRHYTHMIA, SINUS; DOGS; ELECTRIC STIMULATION; HEART; HEART RATE; NOREPINEPHRINE; PEPTIDE FRAGMENTS; SYMPATHOMIMETICS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0035545169     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.2001.0881     Document Type: Article

References (24)

1. Activation of the hyperpolarisation-activated current (if) in sino-atrial node myocytes of the rabbit by vasoactive intestinal peptide
2. Adrenergic inhibition of endogenous acetylcholine release on postganglionic cardiac vagal nerve terminals
3. Colocalization of VIP with other neuropeptides and neurotransmitters in the autonomic nervous system
4. Vagal nerve stimulation releases vasoactive intestinal peptide which increases coronary blood flow
5. A chimeric VIP- PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists
6. Regulation of colonic propulsion by emetic excitatory and inhibitory neurotransmitters
7. Sinus arrhythmia in the dog
8. The contrasting effects of vasoactive intestinal polypeptide (VIP) and noradrenaline on sinus arrhythmia in the anaesthetised dog
9. Vagal stimulation during muscarinic and β-adrenergic blockade increases atrial contractility and heart rate
10. Vagal nerve stimulation increases right ventricular contraction and relaxation and heart rate
11. Vasoactive intestinal polypeptide antagonists attenuate vagally induced tachycardia in the heart
12. An approach to the problems of acid-base balance
13. Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands: Morphological, biochemical and functional studies
14. Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide
15. Potentiation of vagally mediated tachycardia by atropine in the anaesthetized dog
16. Inhibition of neuronal nitric oxide reduces heart rate variability in the anaesthetized dog
17. Effects of neuropeptides on heart rate in dogs: Comparison of VIP, PHI, NPY, CGRP, and NT
18. Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and ventricular refractory periods in conscious and anaesthetised dogs
19. Modulation of neurotransmitter release by presynaptic autoreceptors
20. Heart rate variability
21. Comparison of inotropic and chronotropic effects of vasoactive intestinal peptide in isolated dog atria
22. Peptides in the mammalian cardiovascular system
23. An investigation into the relative merits of pituitary adenylate cyclase-activating polypeptide (PACAP-27) and vasoactive intestinal polypeptide as vagal neurotransmitters in exocrine pancreas of rats
24. Distribution of vasoactive intestinal polypepetide-like immunoreactivity in the mammalian heart